For decades, hepatitis C has been recognized as a major global public health challenge, with an estimated 58 million people living with chronic ...

Direct-acting antivirals (DAAs) can cure hepatitis C (HCV) in more than 95% of individuals treated. But only 1 in 3 people ...

Direct-acting antiviral (DAA) prescribing for hepatitis C virus (HCV) infection peaked in 2015, then declined, according to a research letter published online March 25 in the Journal of the American ...

The Government of Egypt has donated 9,500 doses of hepatitis C vaccines, valued at nearly $80,000, to Ghana, in a move aimed ...

Researchers have identified a promising antiviral compound that blocks hepatitis E replication in early studies. Because it ...

Hailed as breakthrough treatments at their 2013 debut, the number of direct-acting antiviral (DAA) prescriptions to treat ...

A woman who was infected with hepatitis C after having a blood transfusion has said a memorial remembering the victims of the ...

A Burlington man is suing the former owner of a local walk-in clinic, and a doctor who worked there, for $5-million after ...

Human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfection leads to severe systemic inflammation, increasing non-AIDS morbidity and mortality risk. CD39 ectoenzyme on T-cells, which ...

Developed by a team from Tsinghua University and the Beijing-based biopharmaceutical company Huahui Health, the drug Libevitug is the first monoclonal antibody ever approved for viral hepatitis ...

A $5-million lawsuit claims a Burlington man got hepatitis C from an unsterile needle after going to a walk-in clinic to get ...

Combining HCV testing and treatment while in jail with connections to community services after release would reduce ...